MAPT and Alzheimer disease: There is growing evidence that AD is a result of an imbalance in the homeostatic processes that regulate APP, Aβ peptides, and tau.33, 34, 119, 120 Hsp90 is emerging as a central regulator of tau pathology, and many of its co-chaperones influence or regulate tau proteostasis.